EGRP-Supported Epidemiology Consortia
| Title of Initiative | NIH Contacts | Lead Contacts/Principal Investigators | EGRP-Funded Grant (if appropriate) | Consortia Type | Year EGRP Facilitation and/or Funding Began |
|---|---|---|---|---|---|
| African-American Breast Cancer Consortium (ABC) | EGRP/NCI: Elizabeth Gillanders, Ph.D., lgilland@mail.nih.gov |
Lead Contacts/PIs: Chris Haiman, Ph.D. Norris Comprehensive Cancer Center, University of Southern California haiman@usc.edu Funmi Olopade, M.D. |
Cohort, Case-Control | 2008 | |
| Breast and Prostate Cancer Cohort Consortium (BPC3) | EGRP/NCI: Mukesh Verma, Ph.D. vermam@mail.nih.gov DCEG/NCI: |
Lead Contacts/PIs: David Hunter, Sc.D. Channing Laboratory, Harvard University david.hunter@channing.harvard.edu Elio Riboli, M.D., Sc.M., M.P.H. |
Cohort | 2003 | |
| David Hunter, Sc.D. Channing Laboratory, Harvard University david.hunter@channing.harvard.edu |
Characterizing Genetic Susceptibility to Breast and Prostate Cancer; the BPC3 U01CA098233 |
Cohort | 2003 | ||
| Brian Henderson, M.D. University of Southern California/Norris Comprehensive Cancer Center brian.henderson@keck.usc.edu |
Characterizing Genetic Susceptibility to Breast and Prostate Cancer; the BPC3 U01CA098758 |
Cohort | 2003 | ||
| Elio Riboli, M.D., Sc.M., M.P.H. Imperial College, London e.riboli@imperial.ac.uk |
Characterizing Genetic Susceptibility to Breast and Prostate Cancer; the BPC3 U01CA098216 |
Cohort | 2003 | ||
| Michael Thun, M.D., M.S. American Cancer Society michael.thun@cancer.org |
Characterizing Genetic Susceptibility to Breast and Prostate Cancer; the BPC3 U01CA098710 |
Cohort | 2003 | ||
| NCI Cohorts: | |||||
| Demetrius Albanes, M.D. DCEG |
Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study | Cohort | Not Applicable | ||
| Christine Berg, M.D. bergc@mail.nih.gov |
Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial | Cohort | Not Applicable | ||
| Breast Cancer Consortium for Outcomes and Survival (BC2OS) | EGRP/NCI: Daniela Seminara, Ph.D., M.P.H. seminard@mail.nih.gov OCS/NCI: |
Lead Contact/PI: Christine Ambrosone, Ph.D. Roswell Park Cancer Institute Christine.Ambrosone@RoswellPark.org |
|||
Breast Cancer Family Registry (B-CFR) 
|
EGRP/NCI: Sheri Schully, Ph.D. schullys@mail.nih.gov Scott Rogers, M.P.H. (for Informatics) |
Lead Contacts/PIs: Irene Andrulis, Ph.D. Cancer Care Ontario andrulis@mshri.on.ca |
Ontario Cancer Genetics Network (Cancer Care Ontario) U01CA069467 | Familial, Case-control | 1995 |
| Saundra Buys, M.D. University of Utah Health Sciences Center saundra.buys@hci.utah.edu |
Utah Cooperative Breast Cancer Registry at Huntsman Cancer Institute U01CA069446 |
Familial, Case-control | 1995 | ||
| Mary Daly, M.D., Ph.D. Fox Chase Cancer Center mary.daly@fccc.edu |
Family Risk Assessment Program at Fox Chase Cancer Center U01CA069631 |
Familial, Case-control | 1995 | ||
| John Hopper, Ph.D. University of Melbourne j.hopper@unimelb.edu.au |
Australian Breast Cancer Family Registry U01CA069638 |
Familial, Case-control | 1995 | ||
| Esther John, Ph.D., M.S.P.H. Northern California Cancer Center ejohn@nccc.org |
Northern California Cooperative Family Registry for Breast Cancer U01CA069417 |
Familial, Case-control | 1995 | ||
| Mary Beth Terry , Ph.D. Columbia University mt146@columbia.edu |
Metropolitan New York Registry U01CA069398 |
Familial, Case-control | 1995 | ||
The Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) |
EGRP/NCI: Daniela Seminara, Ph.D., M.P.H. seminard@mail.nih.gov |
Lead Contacts/PIs: Georgia Chenevix-Trench, Ph.D. Queensland Institute of Medical Research georgia.trench@qimr.edu.au Douglas Easton, Ph.D. Timothy Rebbeck, Ph.D. |
|||
Prevention and Observation of Surgical Endpoints and Modifiers of Cancer Risk in BRCA 1/2 Mutation Carriers (PROSE-Modifiers Studies) (Collaborative Studies of BRCA 1/2 Mutation Carriers) |
EGRP/NCI: Daniela Seminara, Ph.D., M.P.H., seminard@mail.nih.gov |
Lead Contact/PI: Timothy Rebbeck, Ph.D. University of Pennsylvania trebbeck@cceb.med.upenn.edu |
Modifiers of Cancer Risk in BRCA 1/2 Mutation Carriers R01CA102776 | Cohort study, Nested case-control, Cases only | 2004 |
| Prophylactic Surgery in Carriers of BRCA 1/2 Mutations R01CA083855 | Cohort study, Nested case-control, Cases only | 2000 | |||
| Susan Neuhausen, Ph.D. University of California at Irvine sneuhaus@uci.edu |
Genetic Epidemiology of Breast Cancer – BRCA1 and BRCA R01CA074415 | Cohort study, Nested case-control, Cases only | 1998 | ||
Women,
Cancer and Radiation Exposure (WECARE) |
EGRP/NCI: Daniela Seminara, Ph.D., M.P.H. seminard@mail.nih.gov |
Lead Contact/PI: Jonine Bernstein, Ph.D. Memorial Sloan-Kettering Cancer Center bernstej@mskcc.org |
Breast Cancer, Radiation Exposure, and the ATM Gene (WECARE) U01CA083178 |
Cohort | 2002 |
| Interaction of Radiation, BRCA1/2, and Breast Cancer R01CA097397 | Population-based | 2002 | |||
| Breast Cancer, Radiation and the ATM-CHEK2 Pathway R01CA114236 |
Case-control | 2002 | |||
| Patrick Concannon, Ph.D. University of Virginia pjc6n@virginia.edu |
ATM Mutations in Breast Cancer–-A Functional Approach R01CA112450 |
2002 | |||
| Key to Acronyms Used in Tables | |
|---|---|
| EGRP | Epidemiology and Genetics Research Program |
| CDC | Centers for Disease Control and Prevention |
| DCB | Division of Cancer Biology |
| DCEG | Division of Cancer Epidemiology and Genetics |
| NCI | National Cancer Institute |
| NHGRI | National Human Genome Research Institute |
| NIEHS | National Institute of Environmental Health Sciences |
| NIH | National Institutes of Health |
| OCS | Office of Cancer Survivorship |
| OD | Office of the Director |
